# EDGAR Filing Document

**Accession Number:** 0001064642
**File Stem:** 0001752724-25-211122
**Filing Date:** 2025-8
**Character Count:** 18797
**Document Hash:** 740f71300176ba3ace73069ddf4cf8c5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-211122.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0001752724-25-211122

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250828

**DATE AS OF CHANGE**: 20250828

**PERIOD START**: 20250630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SPDR SERIES TRUST
- **CENTRAL INDEX KEY:** 0001064642

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08839
- **FILM NUMBER:** 251270115

**BUSINESS ADDRESS:**
- **STREET 1:** ONE IRON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 6176643920

**MAIL ADDRESS:**
- **STREET 1:** ONE IRON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STREETTRACKS SERIES TRUST
- **DATE OF NAME CHANGE:** 20000925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INDEX EXCHANGE LISTED SECURITIES TRUST
- **DATE OF NAME CHANGE:** 19980622

## Series and Classes Contracts Data

### SPDR(R) S&P(R) Pharmaceuticals ETF (Series ID: S000012321)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000033537 | SPDR(R) S&P(R) Pharmaceuticals ETF | XPH             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SPDR SERIES TRUST

- **b. Investment Company Act file number:** 811-08839

- **c. CIK number of Registrant:** 0001064642

- **d. LEI of Registrant:** 5493004JVD6CQEEJSS37

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Iron Street

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 617-664-8594

**Item A.2. Information about the Series.**

- **a. Name of Series:** SPDR(R) S&P(R) Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000012321

- **c. LEI of Series:** 549300YVZ2R8N1KQH698

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-06-30

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $161166069.81

**Total Liabilities:** $13210152.07

**Net Assets:** $147955917.74

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000033537 | -5.85%               | -1.61%               | -0.03%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $3471581.01              | $-13584971.39                              |
| Month 2  | $598037.65               | $-3177446.54                               |
| Month 3  | $-7560283.97             | $7314957.63                                |

### Schedule of Portfolio Investments

| Name                             | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ligand Pharmaceuticals Inc       | Ligand Pharmaceuticals Inc                                 | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     24168 | NS      | $2747418.24   | 1.86%             |  |  |  | No            |                  1 | On Loan: —       |
| Viatris Inc                      | Viatris Inc                                                | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    631302 | NS      | $5637526.86   | 3.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     36514 | NS      | $5577513.50   | 3.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc                           | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     66601 | NS      | $5318089.85   | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc        | Mind Medicine MindMed Inc                                  | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |    193902 | NS      | $1258423.98   | 0.85%             |  |  |  | No            |                  1 | On Loan: —       |
| Pacira BioSciences Inc           | Pacira BioSciences Inc                                     | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    161246 | NS      | $3853779.40   | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                       | Harrow Inc                                                 | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     85562 | NS      | $2613063.48   | 1.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Collegium Pharmaceutical Inc     | Collegium Pharmaceutical Inc                               | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     76660 | NS      | $2266836.20   | 1.53%             |  |  |  | No            |                  1 | On Loan: —       |
| Supernus Pharmaceuticals Inc     | Supernus Pharmaceuticals Inc                               | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     96144 | NS      | $3030458.88   | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc                     | CorMedix Inc                                               | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |    168308 | NS      | $2073554.56   | 1.40%             |  |  |  | No            |                  1 | On Loan: —       |
| State Street Global Advisors     | State Street Institutional US Government Money Market Fund | CUSIP: 857492706<br>LEI: 549300BZ5TGIFZUZDZ37 | Long             | STIV             | RF                | US        |    273438 | NS      | $273437.89    | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                       | Zoetis Inc                                                 | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     34083 | NS      | $5315243.85   | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Pharmaceuticals Inc     | EyePoint Pharmaceuticals Inc                               | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |    124739 | NS      | $1173793.99   | 0.79%             |  |  |  | No            |                  1 | On Loan: —       |
| ANI Pharmaceuticals Inc          | ANI Pharmaceuticals Inc                                    | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     54636 | NS      | $3564999.00   | 2.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc    | Amphastar Pharmaceuticals Inc                              | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |    123846 | NS      | $2843504.16   | 1.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Amneal Pharmaceuticals Inc       | Amneal Pharmaceuticals Inc                                 | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |    405117 | NS      | $3277396.53   | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc           | Trevi Therapeutics Inc                                     | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    261963 | NS      | $1432937.61   | 0.97%             |  |  |  | No            |                  1 | On Loan: —       |
| Zevra Therapeutics Inc           | Zevra Therapeutics Inc                                     | CUSIP: 488445206<br>LEI: 254900CU6T74V18Y1W18 | Long             | EC               | CORP              | US        |     81869 | NS      | $721265.89    | 0.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Tarsus Pharmaceuticals Inc       | Tarsus Pharmaceuticals Inc                                 | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    137636 | NS      | $5575634.36   | 3.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Axsome Therapeutics Inc          | Axsome Therapeutics Inc                                    | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     52453 | NS      | $5475568.67   | 3.70%             |  |  |  | No            |                  1 | On Loan: —       |
| WaVe Life Sciences Ltd           | WaVe Life Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |    321600 | NS      | $2090400.00   | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                   | Perrigo Co PLC                                             | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    207128 | NS      | $5534460.16   | 3.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                 | Nuvation Bio Inc                                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    676617 | NS      | $1319403.15   | 0.89%             |  |  |  | No            |                  1 | On Loan: —       |
| State Street Global Advisors     | State Street Navigator Securities Lending Portfolio II     | CUSIP: 857492706<br>LEI: 5493008BJIBKQ5KTIF74 | Long             | STIV             | RF                | US        |  13167264 | NS      | $13167264.00  | 8.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                    | Liquidia Corp                                              | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    173540 | NS      | $2162308.40   | 1.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Organon & Co                     | Organon & Co                                               | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    562410 | NS      | $5444128.80   | 3.68%             |  |  |  | No            |                  1 | On Loan: —       |
| Innoviva Inc                     | Innoviva Inc                                               | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    149970 | NS      | $3012897.30   | 2.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Pfizer Inc                       | Pfizer Inc                                                 | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    231581 | NS      | $5613523.44   | 3.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC         | Jazz Pharmaceuticals PLC                                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     51304 | NS      | $5444380.48   | 3.68%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc            | LENZ Therapeutics Inc                                      | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     41810 | NS      | $1225451.10   | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics Inc        | Edgewise Therapeutics Inc                                  | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    216123 | NS      | $2833372.53   | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc     | Xeris Biopharma Holdings Inc                               | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    617867 | NS      | $2885438.89   | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc         | Enliven Therapeutics Inc                                   | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60202 | NS      | $1207652.12   | 0.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings Inc                           | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    129682 | NS      | $4097951.20   | 2.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                      | Arvinas Inc                                                | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    218768 | NS      | $1610132.48   | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc           | Ocular Therapeutix Inc                                     | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |    319929 | NS      | $2968941.12   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp        | Phibro Animal Health Corp                                  | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     48416 | NS      | $1236544.64   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc         | Elanco Animal Health Inc                                   | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    397274 | NS      | $5673072.72   | 3.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Merck & Co Inc                   | Merck & Co Inc                                             | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     70581 | NS      | $5587191.96   | 3.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                   | Eli Lilly & Co                                             | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      7011 | NS      | $5465284.83   | 3.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                       | Evolus Inc                                                 | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |    154954 | NS      | $1427126.34   | 0.96%             |  |  |  | No            |                  1 | On Loan: —       |
| Royalty Pharma PLC               | Royalty Pharma PLC                                         | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    166493 | NS      | $5998742.79   | 4.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc         | Corcept Therapeutics Inc                                   | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     79577 | NS      | $5840951.80   | 3.95%             |  |  |  | No            |                  1 | On Loan: —       |
| Bristol-Myers Squibb Co          | Bristol-Myers Squibb Co                                    | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    113020 | NS      | $5231695.80   | 3.54%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-29

**Name of Applicant:** SPDR SERIES TRUST

**Signature:** Arthur Jensen

**Name of Signer:** Arthur Jensen

**Title:** Deputy Treasurer